DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trilipix (Fenofibrate) - Drug Dose Omission - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Drug Dose Omission (5)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Trilipix (Fenofibrate) where reactions include drug dose omission. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Trilipix side effects in 41 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-07

Patient: 41 year old female, weighing 124.0 kg (272.8 pounds)

Reactions: Drug Dose Omission, Upper Respiratory Tract Infection, Treatment Noncompliance, Hypertriglyceridaemia

Drug(s) suspected as cause:
Neratinib
    Dosage: 240 mg, 1 in 1 d
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-02-17
    End date: 2011-02-12

Lipitor
    Dosage: 20 mg, daily at bedtime
    Indication: Hypertriglyceridaemia
    Start date: 2010-03-18
    End date: 2011-04-21

Trilipix
    Dosage: 135 mg, daily at bed time
    Indication: Hypertriglyceridaemia
    Start date: 2010-03-18
    End date: 2011-04-21

Other drugs received by patient: Multivitamin ^lappe^; Aluminium Hydroxide; Letrozole; Oxymetazoline Hydrochloride; Oxymetazoline Hydrochloride; Acetylsalicylic Acid; Metformin HCL; Lekovit CA; Magnesium Hydroxide; B-Komplex ^leciva^; Insulin Glargine; Ergocalciferol; Imodium



Possible Trilipix side effects in 41 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-26

Patient: 41 year old female, weighing 124.1 kg (273.1 pounds)

Reactions: Drug Dose Omission, Upper Respiratory Tract Infection, Treatment Noncompliance, Hypertriglyceridaemia

Drug(s) suspected as cause:
Trilipix
    Start date: 2011-05-25

Neratinib; Placebo (Blinded)
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-02-17
    End date: 2011-02-12

Lipitor
    Dosage: daily at bedtime
    Indication: Hypertriglyceridaemia
    Start date: 2010-03-18
    End date: 2011-04-21

Trilipix
    Dosage: daily at bedtime
    Indication: Hypertriglyceridaemia
    Start date: 2010-03-18
    End date: 2010-04-21

Other drugs received by patient: Lantus; Multivitamin ^lappe^; Vitamin B Complex CAP; Aspirin; Imodium Jassen; Glucovance; Coricidin; Femara; Coricidin; Calcium with Vitamin D; Magnesium; Vitamin D



Possible Trilipix side effects in 41 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-27

Patient: 41 year old female, weighing 124.1 kg (273.1 pounds)

Reactions: Drug Dose Omission, Upper Respiratory Tract Infection, Treatment Noncompliance, Hypertriglyceridaemia

Drug(s) suspected as cause:
Trilipix
    Dosage: daily at bedtime
    Indication: Hypertriglyceridaemia
    Start date: 2010-03-18
    End date: 2010-04-21

Trilipix
    Start date: 2011-05-25

Neratinib; Placebo (Blinded)
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-02-17
    End date: 2011-02-12

Lipitor
    Dosage: daily at bedtime
    Indication: Hypertriglyceridaemia
    Start date: 2010-03-18
    End date: 2011-04-21

Other drugs received by patient: Glucovance; Calcium with Vitamin D; Femara; Magnesium; Vitamin D; Coricidin; Multivitamin ^lappe^; Vitamin B Complex CAP; Aspirin; Lantus; Imodium Jassen; Coricidin



Possible Trilipix side effects in female

Reported by a consumer/non-health professional from United States on 2011-11-16

Patient: female, weighing 124.0 kg (272.8 pounds)

Reactions: Drug Dose Omission, Upper Respiratory Tract Infection, Treatment Noncompliance, Hypertriglyceridaemia

Drug(s) suspected as cause:
Trilipix
    Dosage: 135 mg, 1x/day
    Start date: 2011-05-25

Lipitor
    Dosage: 20 mg, daily at bedtime
    Indication: Hypertriglyceridaemia
    Start date: 2010-03-18
    End date: 2011-04-21

Trilipix
    Dosage: 135 mg, daily at bedtime
    Indication: Hypertriglyceridaemia
    Start date: 2010-03-18
    End date: 2011-04-21

Neratinib
    Dosage: blinded (240mg, 1 in 1 d)
    Administration route: Oral
    Start date: 2010-02-17
    End date: 2011-02-12

Other drugs received by patient: Multivitamin ^lappe^; Letrozole; Lekovit CA; Oxymetazoline Hydrochloride; Acetylsalicylic Acid; Imodium; Aludrox; Insulin Glargine; B Komplex; Oxymetazoline Hydrochloride; Glibomet; Ergocalciferol



Possible Trilipix side effects in 41 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-05

Patient: 41 year old female, weighing 124.1 kg (273.1 pounds)

Reactions: Drug Dose Omission, Upper Respiratory Tract Infection, Treatment Noncompliance, Hypertriglyceridaemia

Drug(s) suspected as cause:
Neratinib; Placebo (Blinded)
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-02-17
    End date: 2011-02-12

Lipitor
    Dosage: daily at bedtime
    Indication: Hypertriglyceridaemia
    Start date: 2010-03-18
    End date: 2011-04-21

Trilipix
    Start date: 2011-05-25

Trilipix
    Dosage: daily at bedtime
    Indication: Hypertriglyceridaemia
    Start date: 2010-03-18
    End date: 2010-04-21

Other drugs received by patient: Vitamin D; Vitamin B Complex CAP; Multivitamin ^lappe^; Glucovance; Aspirin; Imodium Jassen; Coricidin; Femara; Calcium with Vitamin D; Lantus; Coricidin; Magnesium

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017